Average Co-Inventor Count = 7.80
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (13 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
3. Msd R&d (china) Co., Ltd. (1 from 10 patents)
15 patents:
1. 10358435 - Triazolyl pyrimidinone compounds as PDE2 inhibitors
2. 10287293 - Bicyclic heterocyclic compounds as PDE2 inhibitors
3. 10208060 - Inhibitors of HIF prolyl hydroxylase
4. 10174037 - Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
5. 10160762 - 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
6. 10000501 - Inhibitors of HIF prolyl hydroxylase
7. 9969752 - Inhibitors of HIF prolyl hydroxylase
8. 9815796 - Pyrimidone carboxamide compounds as PDE2 inhibitors
9. 9708270 - Substituted spiropiperidinyl compounds useful as GPR120 agonists
10. 8507512 - Soluble guanylate cyclase activators
11. 8455638 - Soluble guanylate cyclase activators
12. 7968589 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
13. 7687534 - Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
14. 7598398 - Acyl indoles, compositions containing such compounds and methods of use
15. 7301036 - Cyclic guanidines, compositions containing such compounds and methods of use